Study Group: Radiation Oncologists(?)
Council Members in this Study Group: 358
Request a survey with this Study Group
Leading Experts in this Study Group
Charles Bennett, M.D.
Radiation Oncologist
Robert Boissoneault Oncology Institute
Charles Bennett, MD, is a board certified Radiation Oncologist at the Robert Boissoneault Oncology Institute, Florida. He specializes in breast, prostate and metastatic cancer treatment with radiopharmaceauticals. Dr. Bennett has participated in several national forums dealing with radiopharmaceautical...
Radiation Oncologist
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Martin Fuss, MD, is a Professor and Program Director of Image-Guided Radiation Therapy (IGRT) in the Department of Radiation Medicine at Oregon Health and Science University. Previously, Dr. Fuss was an Associate Professor in the Department of Radiation Oncology at University of Texas Health Science...
Sasa Mutic, MSAssociate Professor of Radiation Oncology
Washington University in St. Louis-School of Medicine
Sasa Mutic, MS, is the Chief of Clinical Medical Physics and Associate Professor of Radiation Oncology at Mallinckrodt Institute of Radiology at Washington University School of Medicine, Missouri. His main clinical and research interests include implementation of different medical imaging modalities...
Radiation Oncologist
St. Vincent's Comprehensive Cancer Center
Lawrence Tena, MD, is an Attending Physician in the Department of Radiation Oncology at St. Vincent's Comprehensive Cancer Center in New York. He is also an Assistant Professor of Radiation Oncology at the New York Medical College and an Associate Adjunct at the New York Eye and Ear Infirmary. Dr. Tena...
Radiation Oncologist-in-Chief
Rhode Island Hospital
David Wazer, MD, is the Radiation Oncologist-in-Chief at Tufts Medical Center in Boston, MA and Rhode Island Hospital in Providence, RI. Under his direction, the hospitals provide state-of-the-art care including intensity modulated radiation therapy (IMRT), Image guided radiation therapy (IGRT), stereotactic...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Radiation Oncologists (EU) | 79 |
| Oncologists (US) | 2247 |
| Breast Oncologists (US) | 314 |
| Radiologists (US) | 611 |
| Physicians who Perform Procedures using MammoSite | 44 |
| Physicians who Perform Radiosurgery (US) | 24 |
| Radiologists who Perform IMRT | 21 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This article is important because: 1) Costly cancer drugs are unsustainable in our healthcare system 2) Indiscriminate use of Avastin swallows up money that would be better spent elsewhere
A single payer, national system does work, but may not necessarily be in the best interest of all parties. Yes this type of system is 'free' to the users, but is funded through higher taxes than paid in the US.
SenoRx has released the Contura system which provides a superior system when compared to the Mammosite Breast Brachytherapy System. These advantages include: 1. Better dosimetry, opening the door for more patients to be treated by avoiding the elimination of some patients due to skin spacing...
Essentially we are moving into an arena where cancer drugs will be more and more specific to individual groups of patients with cancer. For example in breast cancer all patients used to be treated the same. Now patients with tumours that are ER positive are given hormonal therapies and not those with...
Varian and Elekta's new arc treatments improve workflow, efficiency, and give radiation oncologists a better alternative to tomotherapy.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Department Chair
- Physician - Division Head
- Research Scientist
- Professor
- Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms